Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2013 Arterial and Venous Access and Hemostasis for PCI The Interventional Cardiac Catheterization Handbook 3rd Edition, Elsevier Saunders Puibl, Philadelphia PA, 2013.  Pp 38-82.
2. 2012 Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascularmechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction American Heart Journal May2012 vol 163 (5)
3. 2012 Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.   Heart:10.1136/heartjnl-2012-302126
4. 2012 Current Approaches to Prevention and Management of Reperfusion Injury Management of Myocardial Reperfusion Injury.Kaski JC, Hausenloy DJ, Gersh BJ, Yellon DM., Springer Publ 2012
5. 2012 Randomized, Controlled Study of Telcagepant in Patients with Migraine and Coronary Artery Disease. Headache. 2012 Feb; 52(2):224-235. doi: 10.1111/j.1526-4610.2011.02052.x. Epub 2012 Jan 6.
6. 2011 The academic research consortium governance charter JACCCardiovasc Interv 2011 May; 4(5):595-6
7. 2011 Autopsy validation study of the academic research consortium stent thrombosis definition JACCCardiovasc Interv. 2011 May; 4(5):554-9.
8. 2011 Transradial PCI in women: problem solved or clinical equipoise? J Invasive Cardiol 2011Mar; 23(3):4 p preceding 101.
9. 2011 Theclinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. ENDEAVOR Japan Investigators Cardiovasc Revasc Med. 2011 Sep-Oct; 12(5):273-9. Epub 2011Mar 1.
10. 2011 Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011 Jan; 32(2):205-17. Epub 2011 Jan 6
11. 2011 Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Am Coll Cardiol 2011 Jan 18; 57(3):253-69. Epub 2011 Jan 7
12. 2011 Impact of early,late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction andinfarct size as determined by cardiovascular magnetic resonance imaging. J. Electrocardiol 2011 Jan-Feb; 44(1):36-41
13. 2011 Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST- segment elevation myocardial infarction. Catheter Cardiovasc Interv 2011 Feb 1; 77(2):174-81. doi: 10.1002/ccd.22665.
14. 2011 Standardized Bleeding Definitions for Cardiovascular Clinical Trials:A Consensus Report From the Bleeding Academic Research Consortium Circulation. 2011;123:2736-2747
15. 2011 Commentary: International collaboration needed on device clinical standards BMJ 2011;342:d2952. doi: 10.1136/bmj.d2952
16. 2011 Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform: Report of a policy conference of the European Society of Cardiology Eur Heart J. 2011 [E pub] doi: 1093/eurheartj/ehr171
17. 2011 Toward a more materialistic medicine: the value of authentic materialism within current and future medical practice. J Altem Complement Med. 2011 Sep; 17(9):859-65. Epub 2011 Aug 11
18. 2011 Learning to walk before we run: the mechanics of medical intervention for peripheralarterial diaease J Am Coll Cardiol. 2011 Aug 30; 58(10):1077-9.
19. 2011 A new era of prospective real-world safety evaluationprimary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study) JACC Cardiovasc Interv. 2011 Dec; 4(12):1298-309.
20. 2011 Troponin measurements during drug development- considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the CardiacSafety Research Consortium, the Duke Clinical Research Am Heart J.2011 Jul; 162(1):64-73.
21. 2011 Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study Headache 2011 Jun; 51(6):954-60. doi: 10.1111/j.1526-4610.2011.01901.x.
22. 2010 The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing. Am Heart J. 2010 Dec;160(6):1023-8. Review.
23. 2010 Electrocardiographic assessment for therapeuticproteins--scientific discussion. Am Heart J. 2010 Oct; 160(4):627-34
24. 2010 Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan- stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. Am Heart J. 2010Oct; 160(4):619-26. Review.
25. 2010 Incremental benefit of 80-lead electrocardiogram body surfacemapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST- elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling FasterTreatment of Myocardial Infarction (OCCULT MI) trial. Acad Emerg Med. 2010 Sep; 17(9):932-9.
26. 2010 Complement Med. Teaching yoga to seniors: essential considerations to enhance safety and reduce risk in a uniquely vulnerable age group. J Altem 2010 Aug; 16(8):899-905.
27. 2010 Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development Am Heart J. 2010 May; 159(5):716-29
28. 2010 Evidence strength in FDA premarket approval of cardiovascular devices. JAMA, 2010 Apr 28;303(16):1599-600;
29. 2010 Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independentpredictorof cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanteriorwall ST- segment elevation myocardial infarction undergoing primary percutaneous coronary intervention J. Am Cardiol 2010 Apr 15; 105(8):1065- 9. Epub 2010 Feb 20.
30. 2010 Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database Am Heart J 2010 Mar; 159(3):462-470.e1
31. 2010 Planning the Safety of Atrial FibrillationAblation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac SafetyResearch Consortium "Incubator" Think Tank. Am Heart J. 2010 Jan; 159(1):17-24. Review
32. 2010 Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction Catheter Cardiovasc Interv.2010 Apr 1;75(5):701-6
33. 2010 RR- interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. Heart Rhythm 2010 Jan;7(1):65-71
34. 2009 What Do ‘‘We’’ Want and Need to Know About Prayer and Healing?The Mantra Study Project Journal of Alternative and Complementary Medicine 2009; 15(12) :1259-1261
35. 2009 Pre-excitation and myocardial infarction: conditions with confusing electrocardiographic manifestations. J Electrocardiol. 2008 Nov-Dec; 41(6):679-82. Epub 2008 Jul 7. Erratum in: J Electrocardiol. 2009 Mar-Apr; 42(2):189
36. 2009 Meeting report ESC forum on drug eluting stents. European Heart House, Nice, 27-28 September 2007.European Society of Cardiology.EuroIntervention. 2009 Jan; 4(4):427-36.
37. 2009 ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.Eur Heart J. 2009 Jan; 30(2):152-61. Epub 2008 Nov 26.
38. 2009 The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psycho-educational intervention improves depression and clinical symptoms in patients with chronic heart failure Am Heart J. 2009 Jan; 157(1):84-90
39. 2009 Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction Eur Heart J. 2009 Apr; 30(7):757-64. Epub 2009 Feb 7.
40. 2009 Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36. J Am Coll Cardiol. 2009 Apr 21; 53(16):1422-4
41. 2009 New precompetitive paradigms: focus on cardiac safety. Am Heart J. 2009 May; 157(5):825-6
42. 2009 Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med. 2009 May 21; 360(21):2176-90. Epub 2009 Mar 30.
43. 2009 In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study JACC CardiovascImaging.2009 Jul; 2(7):858-68.
44. 2009 QT as a safety biomarker in drug development Clin Pharmacol Ther. 2009Jul; 86(1): 101-4.Epub 2009 May 27.
45. 2009 Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial. Euro Intervention.2009 Sep; 5(4):417-24
46. 2009 CSRC/HESI Writing Group Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative Am Heart J. 2009 Sep; 158(3):317-26. Epub 2009 Jul 23
47. 2009 Acute Detection of ST-Elevation Myocardial Infarction Missed on Standard 12-Lead ECG With a Novel 80-Lead Real-Time Digital Body Surface Map: Primary Results From the Multicenter OCCULT MI Trial Ann Emerg Med. 2009 Sep 18.
48. 2009 Randomized Comparison of Primary Percutaneous Coronary Intervention With Combined Proximal Embolic Protection and Thrombus Aspiration Versus Primary Percutaneous Coronary Intervention Alone in ST-Segment Elevation Myocardial Infarction: The PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) Study. J Am Coll Cardiol Intv 2009; 2 934-943
49. 2009 From ST-elevation myocardial infarction to ST elevation with no myocardial infarction- review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices Journal of Electrocardiology 2009; 42: 487-493
50. 2008 Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry CatheterCardiovasic Interv. 2008 Aug 1; 72(2):196-203
51. 2008 Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis. Int J Cardiol. 2008 Nov 12; 130(2):220-6. Epub 2008 Mar 4
52. 2008 Complementary and Alternative Medical Therapy in Cardiovascular Care 12th Edition Hurst:The Heart, Fuster V, O’Rourke AR et al eds., McGraw HillPubl 2008.
53. 2008 The Touch That Heals: The Uses and Meanings of Touch in the Clinical Encounter J Altern Complement Med 2008;14:3,321-327
54. 2008 Direct Inhibition of_-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators, Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation. 2008;117:886-896
55. 2008 A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for Treatment for Single and Multivessel Coronary Disease: Primary Results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II Study J Am Coll Cardiol 2008, 51:1543-1552
56. 2008 Postmarket evaluation of breakthrough technologies. Am Heart J. 2008 Aug; 156(2):201-8
57. 2008 Simultaneous Comparison of Three Derived 12-lead ECGs with Standard ECG at Rest and during Percutaneous Coronary Occlusion J Electrocardiol 2008, in press
58. 2008 Simultaneous comparison of 3 derived 12 lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion J of Electrocardiology 2008;41(3):230-237
59. 2008 :Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). Am Heart J. 2008 Jun; 155(6):1090-6. Epub 2008 Jan 30.
60. 2008 Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial J Invasive Cardiol. 2008 Jul; 20(7):335-41
61. 2008 Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias Europace. 2008 Aug; 10(8):988-97. Epub 2008 May 14.
62. 2008 Post-market evaluation of breakthrough technologies Am Heart J. 2008 Aug; 156(2):201-8
63. 2007 The Truth and Consequences of the COURAGE Trial J. Am Col Card 2007, 50: 16,1598-1603.
64. 2007 Thrombosis and drug-eluting stents J. Am Col Card 2007,50: 2,109-118
65. 2007 Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies J of Biopharm Stat 2007;17(1):19-21
66. 2007 Comparison of Myocardial Reperfusion in Patients Undergoing Percutaneous Coronary Intervention in STSegment Elevation Acute Myocardial Infarction With-vs-Without Diabetes Mellitus. From The EMERALD Trial Am J Card July 2007, in press
67. 2007 Presence, healing, and healers: an introduction to mindfulness, meditation, and its relevance to stress reduction and health for patients, physicians and health-care professions Vogel J, Krucoff MW, eds. Integrative Cardiology. New York, NY: McGraw-Hill; 2007:563-571.
68. 2007 Noetic Therapy, Spirituality, and Prayer Vogel J, Krucoff MW, eds. Integrative Cardiology. New York, NY: McGraw-Hill; 2007:209-229.
69. 2007 Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation Drug Discovery Today 2007, 4: 2,43-46.
70. 2007 Electrocardiographic Factors Playing A Role In Ischemic Ventricular Fibrillation In ST Elevation Myocardial Infarction Are Related To The Culprit Artery 52.                AP Heart Rhythm 2007, in press
71. 2007 Acute myocardial infarction with hyperoxemic therapy J. Am Col Card 2007, 50: 5,397-405
72. 2007 Impact of time to treatment on myocardial reperfusion and infarct size with primary Percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial). Am J Card 2007:1680-1686.
73. 2006 Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high fidelity, intracardiac electrogram monitoring systems with long-range telemetry in an ambulatory porcine model. J. Am Col Card 2006,48: 11,2306-2314
74. 2006 Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicenter CASTEMI study. Eur Heart J 2006; 27:2516-2523
75. 2006 Initial Experience with a Novel Coronary Rinsing and Thrombectomy System: “Rinspiration”. J Invasive Cardiol 2006; 18:188-192
76. 2006 Letter to Editor J Am Col Card 2006:47(2); 471.
77. 2006 Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination J Electrocardio 2006:39:157-159.
78. 2006 Simultaneous Restenosis of Taxus and Cypher Drug-Eluting Stents. J Invasive Cardiol 2006; 18:557
79. 2005 Surrogates, Sub-studies, and real clinical end points in trials of drug-eluting stents J Am Coll Cardiol 2005; 45:1206-1212
80. 2005 Letter to Editor Lancet 2005; 366:1770
81. 2005 Integrating complementary medicine into cardiovascular medicine: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol 2005; 46:184-221.
82. 2005 Comparison of ST-Segment Resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials), Am J Cardiol 2005; 95:611-6114.
83. 2005 Clinical utility of the Food and Drug Administration electrocardiogram warehouse: a paradigm for the critical pathway initiative J Electrocardio 2005:4S:175-179.
84. 2005 Letter from Editor J Altern Complement Med 2005; 6:949.
85. 2005 Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion. J.CARREV, 2005:05.002, in press
86. 2005 A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy Eur Heart J 2005:26:17: 1726-1733.
87. 2005 Clinical Utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative J Electrocardio 2005: 4S:175-179
88. 2005 Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualization of Noetic Trainings (MANTRA) II randomized study The Lancet, 2005; 366:211-224.
89. 2004 Prayer and Cardiovascular Disease Complementary Clinical Medicine:The Clinical Handbook Oz M, Stein RA eds., Humana Press 2004.
90. 2004 Permanently Implantable Diagnostic Computerized Devices: Where is the Regulatory Bar? Journal of Electrocardiology 2004; 37:68-70.
91. 2004 Practice Standards for Electrocardiographic Monitoring in Hospital Settings.An American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young Circulation AHA 2004
92. 2004 Outcome of Percutaneous Coronary Intervention Versus Coronary Bypass Grafting for Patients with Low Left Ventricular Ejection Fractions, Unstable Angina Pectoris, and Risk Factors for Adverse Outcomes with Bypass (the AWESOME Randomized Trail and Registry). Am J Cardiol 2004 94: 118-120.
93. 2004 Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. Am Heart J. 2004 May; 147(5):847-52.
94. 2004 Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004 Feb 18; 43(4):549-56.
95. 2004 Prayer and Cardiovascular Disease Complementary and Integrative Therapies for Cardiovascular DiseaseFrishman WH, Weintraub MI, Micozzi MS eds., Elsevier Mosby 2004
96. 2004 Complementary and Alternative Medical Therapies:Opening the Door to the Science and Practice of Integrative Medicine in Cardiovascular Care Hurst:The Heart, Logue RB, Schlant RC et al eds., McGraw HillPubl 2004
97. 2003 Recurrance of ST Elevation After Early Reperfusion as a Marker of Prognosis in ST Elevation Infarction. Abstract. Suppl to J Amer Coll Cardiol. Pg. 362A.
98. 2003 Opening the window of facilitated percutaneous coronary intervention in acute infarction: the role of combined llb/llla inhibition and thrombolytic therapy Abstract. Suppl to J Amer Coll Cardiol. Pg. 334A.
99. 2003 The mirror-like serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction Am Heart J, September 2003, in press.
100. 2003 Healing prayer outcomes studies: consensus recommendations Alt Therapies 2003; 9, No. 3, (suppl): A44-A53.
101. 2003 Correlations Between Pre-procedure Mood and Clinical Outcome in Patients Undergoing Coronary Angioplasty In pressCardiology-In-Review, July 2003
102. 2003 American College of Cardiology Clinical Expert Consensus Document on the Integration of Complementary Medicine Into Cardiovascular Medicine. J Am Coll Cardiol, in press, 2003
103. 2003 “Mirror-lake” serial relationship of Electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction American Heart Journal 2003, Vol. 146, No. 5, pp 757-763.
104. 2003 Usefulness of Frequent Arrhythmias after Epicardial Recanalization in Anterior Wall Acute Myocardial Infarction as a Marker of Cellular Injury Leading to Poor Recovery of Left Ventricular Function Am J Cardiol. 2003 Nov 15; 92(10):1143-9.
105. 2003 Association of the Timing of ST-Segment Resolution with TIMI Myocardial Perfusion Grade in Acute Myocardial Infarction. Circulation in press 2003.
106. 2003 Efficacy of a Novel P-Selectin Antagonist, rPSGL-lg for Reperfusion Therapy in Acute Myocardial Infarction: The Rapsody Trial Abstract. Suppl to J Amer Coll Cardiol. Pg.404A.
107. 2002 Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass.Outcome of diabetic patients in the awesome randomized trial and registry. Journal of the American College of Cardiology 2002, Vol. 40, No. 9, pp1555-1565.
108. 2002 Ischemia monitoring, state of the art J Electrocard 2002; 35(suppl):207-237
109. 2002 Comparison of electrocardiogram and intrathoracic electrogram signals for detection of ischemic ST segment changes during normal sinus and ventricular paced rhythms. J Cardiovasc Electrophysiol 2002; 13:990-995
110. 2002 Spiritual intervention in acute cardiac care: the monitoring and actualization of noetic trainings (MANTRA) study projec Behind and Beyond the Brain Bial Foundation Publ, 2002: 293-313
111. 2002 Slowed ST-segment recovery despite early infarct artery patency in patients with Q waves at presentation of a first acute myocardial infarction:Implications of initial Q waves on myocyte reperfusion. Eur Heart J 2002; 23:1449-1455.
112. 2002 Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass J Am Coll of Cardiol 2002:39(No. 2)266-273.
113. 2001 Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. Heart Attack:The Public Health Challenge for the New Millennium 2001: (spring) 60-64.
114. 2001 Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. Am Heart J.2001; 142:760-769
115. 2001 Association of non-invasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2001; 88: 342-346
116. 2001 Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass:A multicenter, randomized trial. J Am Coll of Cardiol 2001:38(No. 1)143-149
117. 2001 Shifting the open-artery hypothesis downstream:The quest for optimal reperfusion J Am Coll of Cardiol 2001; 37(No.1)9-18
118. 2000 Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery J Clin Anes 12:136-41, 2000.
119. 2000 Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12 lead ST segment resolution analysis:Re-examining the “gold standard” for myocardial reperfusion assessment. J Am Coll of Cardiol 2000:35:3:655-672
120. 2000 A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction:the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). J Am Coll of Cardiol 2000; 36(5)1500-1506
121. 2000 Local delivery of heparin post-PTCA:A multicenter randomized pilot study Catheterization and Cardiovascular Diagnosis 2000; 49:461-467.
122. 2000 Real-time application of continuous 12-lead ST-segment monitoring:3 case studies Critical Care Nurse 2000; 20(No.2):93-99
123. 2000 Maximum likelihood estimation of time to first event when data gaps and multiple events are possible. Biometrics June 2000; submitted
124. 2000 What is the role of advanced Electrocardiology Challenges in Acute Coronary Syndromes,. De Bono, Sobel (eds), Blackwell Science, UK, 2000.
125. 1999 Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis Am Heart J1999; 138(3 Pt 1):533-539
126. 1999 Imagery, Touch, Therapy, Stress Relaxation and Prayer as Adjuncts to Acute Interventional Cardiac Care: The Mantra Study Project Pilot Abstract. Interventional Meeting on Interventional Cardiology, pg. 43.
127. 1999 Information Lost of Gained: New Methods for Analyzing Failure Time Date Abstract 33, Suppl to Controlled Clinical Trials, Vol. 20
128. 1999 In Patients with TIMI 3 Flow, Rapid 50% Resolution of ST Segment Elevation, Assessed by Continuous Monitoring, is Associated with Better Ventricular Function at 48 Hours J Amer CollCardiol.
129. 1999 Hirulog Reduces Re-Ischaemic Episodes as Assessed by Continuous ST-Segment Monitoring Following Acute Myocardial Infarction Treated With Streptokinase Abstract 1184-166, Suppl to J Amer Coll Cardiol.
130. 1999 Long-Term Survival of Patients with Severe Left Ventricular Dysfunction and Multivessel Coronary Artery Disease: 5-Year Results of the High Risk Myocardial Ischemia Trial. Abstract 1049-9, Suppl to J Amer Coll Cardiol.
131. 1998 QT prolongation and dispersion in myocardial ischemia and infarction. J Electrocard 1998; 30(suppl):204-7
132. 1998 Continuous ST-Segment RecoveryAnalysis is More Predictive of Clinical Outcome Than Static Serial Analysis After Thrombolytic Therapy for Acute MI Circulation, (Suppl.) 405
133. 1998 Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy:The GUSTO-I ST segment monitoring substudy J Am Coll of Cardiol 1998; 26(4):783-9
134. 1998 Randomized Integrative Therapies in Interventional Patients with Unstable Angina:TheMonitoring & Actualization of Noetic Training (MANTRA) Feasibility Pilot Circulation, (Suppl.) 1458.
135. 1998 Rethinking theprognostic significance of ST-segment depression during acute myocardial infarction in the thrombolytic era Circulation,(Suppl.) 779
136. 1998 Continuous ST-Segment Recovery Analysis is More Predictive of Clinical Outcome Than Static Serial Analysis After Thrombolytic Therapy for Acute MI Euro Heart Jour., 1998
137. 1998 Speed and stability of reperfusion do not explain excess mortality in the elderly after acute myocardial infarction. Circulation, (Suppl.) 3309
138. 1998 ST-Segment Parameters and the Gusto-I Mortality Model:AnotherRisk-Stratification Tool in Acute Myocardial Infarction J Amer Coll Cardiol., 1998
139. 1998 A Comparison of Static Serial vs. Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI. J Amer Coll Cardiol., 1998
140. 1997 The paradigm for anti-platelet effect on continuous 12-lead ST-segment recovery in acute MI JAm Col Cardiol 1997;29(2)(suppl A):185A
141. 1997 Seamless physiologic monitoring:from intuition to execution Digital Cardiac Imaging in the 21st Century:A Primer.The Cardiac and Vascular Information Working Group, 1997:98-99
142. 1997 Incidence and long term significance of transient st segment deviationin hemodialysis patients. Clinical Nephrology, 1997
143. 1997 Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease Circulation 1997; 96(No6);1761-1769
144. 1997 Device Implementation, Validation, Application (DIVA) assessment of two continuous 12-lead ECG monitors during PTCA:description of the validation method and implications for clinical trials J of Electrocardiol, 1997, p223-227
145. 1997 Comparative Prognostic Significance Versus Independent Resolution of ST-Segment Depression Relative to ST-Segment Elevation During Acute Myocardial Infarction J Am Coll of Cardiol, 1997; 30:1478-1483
146. 1997 Electrographic differentiation of the ST-Segment Depression of Acute Myocardial Injury Due to the Left Circumflex Artery Occlusion From That of Myocardial Ischemia of Non-Occlusive Etiologies Am J Cardiol. 1997; 80:512-13
147. 1997 Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrelin in acute myocardial infarction: results of a randomized, placebo-controlled, dose-ranging trial. Circulation 1997; 95(4):846-854
148. 1997 Is continuous ST monitoring a betterpredictor of outcome than enrolling electrocardiogram in acute myocardial infarction? J Am Col Cardiol 1997; 29(2)(supplA):431A.
149. 1997 Noninvasive identification of the infarct artery fromzone activity in the true peak surface 12 lead ECG. J Am Col Cardiol 1997; 29(2)(suppl A):430A
150. 1997 Temporal distribution of important ECG information in patients with MI:when should you take the next ECG after lytics? J Am Col Cardiol 1997; 29(2)(suppl A):131A
151. 1997 ST-segment recovery parameterspredictive of outcome in AMI: variability with infarct artery location and implications for therapeutic targets J Am Col Cardiol1997; 29(2)(suppl A):412A
152. 1997 Upright posture with a flexible femoral sheath:safety and cost results from 900 patients in the “heads up” trial J AmCol Cardiol 1997; 29(2)(suppl A):278A
153. 1997 Occurrence of Ventricular Fibrillation during acute myocardial infarction:prediction by dynamic continuous 12 lead ECG ST-segment variables J Am Col Cardiol 1997; 29(2)(suppl A):431A
154. 1997 The relationship between coronary artery dissection and long-term clinical outcome:results from the CRAC (compliance related acute complication) trial J Am Col Cardiol 1997; 29(2)(suppl A):277A
155. 1997 Temporal Distribution of Important ECG Information in Patients With MI: When Should You Take the Next ECG After Lytics? JACC, March1997.
156. 1996 Incidence and clinical relevance of occurrence of bundle-branch block in patients treated with thrombolytic therapy Circulation 1996; 94(10):2424-8
157. 1995 Noninvasive assessment of speed and stability of infarct-related artery reperfusion:results of the GUSTO ST-segment monitoring study J Am Col Cardiol 1995; 25:1552-1557.
158. 1995 Beneficial Impact of a Platelet Inhibitor, Integrelin, on Parameters of Continuous ST-Segment Recovery During Myocardial Infarction Circulation, October 1995
159. 1995 Serial Changes of QT Dispersion after Thrombolytic Therapy:IsThere any Useful Information? Circulation, October 1995.
160. 1995 Interventions may not be Necessary in Acute MyocardialInfarction Patients with £ 200 uV ST-Segment Elevation, Irrespective of Infarct Artery Patency Circulation,October 1995.
161. 1995 Noninvasive Definition of failed reperfusion at the bedside:looking beyond the tip of the catheter Acute Coronary Care Second Edition.Califf RM, Mark DB, Wagner GS (eds). St Louis:Mosby- Year Book, Inc, 1995:443-468
162. 1995 The “Long Long” Balloon Pilot:Dilatation of Class C Coronary Lesions UsingSlow, Oscillating, Prolonged Inflation of 40 mm Balloons JACC, March 1995
163. 1995 Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995; 91(7):1929-35
164. 1995 Diagnosis and Treatment of Acute Coronary Ischemic Syndromes:An Update for 1995 The J of the Ark Med Society 1995; 92(3):129-31.
165. 1995 The Incidence andClinical Relevance of Bundle Branch Block in Patients with Acute Myocardial Infarction Treated with Thrombolytic Agents JACC, March 1995
166. 1995 Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors Am J Med 1995; 99(3):270-5
167. 1994 The High Risk Myocardial Ischemia Trial (HIRMIT) Randomized Pilot & Registry: 6 Day, 6 Week, 6 Month & 1 YearMortality Circulation, October 1994
168. 1994 Univariate Relationships Between Mortality & Parameters of Continuous 12-Lead ST-Segment Deviation and Recovery After Thrombolytic Therapy for Acute Infarction. Circulation, October 1994.
169. 1994 Discordance Between Angiographic Patency and ST-Segment Recovery in Acute Myocardial Infarction:Is It Time to Re-think the “GoldStandard”? Circulation, October 1994
170. 1994 Panoramic display of the orderly sequenced 12-lead ECG. J Electrocard 1994;27:347-352
171. 1994 Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction:a new look at an old study.The thrombolysis and angioplasty in myocardial infarction (TAMI) study group. Coronary Artery Disease 1994; 5(7):611-5.
172. 1994 Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Am J Cardiol 1994; 73(15):1069-74
173. 1994 Comparison between standard and monitoring-compatible torso limb lead placement of ST-segment measurements at rest and during active myocardial ischemia. Am JCardiol 1994; 74:997-1007
174. 1994 Reassessing the clinical significance of ST-segment depression that occurs concomitantly with the ST-segment elevation during acute myocardial infarction with the use of continuous ST-segment analysis J Electrocard 1994; 27(suppl):256-9
175. 1994 The impact of autoperfusion on quantitative electrocardiographic parameters of ischemia severity, extent, and "burden" during salvage of elective coronary angioplasty J Invas Cardiol 1994; 6:234-40
176. 1994 From signal/noise to information content/noise:Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring J Electrocard1994; 27(suppl):233-237
177. 1994 Gender Differences in Speed and Stability of Coronary Reperfusion Following Thrombolytic Therapy for Acute MyocardialInfarction JACC, March 1994
178. 1994 Differentiation of “Benign MirrorImage” from High Risk Reciprocal ST-Depression Using Continuous 12-Lead ST-Segment Recovery Analysis JACC, March 1994
179. 1993 Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study:Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation1993; 88:437-446
180. 1993 Comparison ofContinuous ST-Segment Recovery Analysis with Static ECG Methods for Noninvasive Patency Assessment in AcuteMyocardial Infarction. Circulation, October 1993.
181. 1993 Effects of Peak ST-Deviation and Infarct Artery Location on Accuracy of PatencyAssessment by Continuous ST-Segment Recovery Analysis in the GUSTO Trial. Circulation, October 1993.
182. 1993 Simultaneous Holter, VCG and ECG ST-Monitoring During Transient Occlusion and Reperfusion:Implications for Comparing or Combining Data Sets Circulation, October 1993
183. 1993 Cyclic Changes in Coronary Flow:Underlying Disease, Result of Therapy or Both? Circulation, October1993.
184. 1993 Safety and Efficacy ofRandomized, Single Blind Nitroglycerin vs. Diltiazem Infusion in Patients with Severe Unstable Angina JACC, March 1993.
185. 1993 Simultaneous Holter, VCG, and ECG ST-monitoring during transient occlusion and reperfusion: implications for comparing or combining data sets Circulation1993; 88:I-306.
186. 1993 Comparison of continuous ST-segment recovery analysis with Static ECG methods for noninvasive patency assessment in acute myocardial infarction Circulation 1993; 88:I-306
187. 1993 Effects of peak ST deviation and infarct artery location on accuracy of patency assessment by continuous ST-segment recovery analysis in the GUSTO trial Circulation 1993; 88:I-258
188. 1993 Rebound increase in thrombin activity after cessation of intravenous Heparin Circulation 1993; 88:I-202
189. 1993 Rethinking classical ECG patterns of ischemia and infarction:insights from investigations with continuous ECG monitoring. The Newspaper of Cardiol.1993
190. 1993 Patient management following percutaneous Transluminal Coronary revascularization Interventional Cardiovascular Medicine:Principles and Practice, Roubin G, Califf R et al eds.Churchill Livingston, 1993:643-658
191. 1993 Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy: study design and technical considerations J Electrocard 1993; 26(suppl):249-255
192. 1993 Clinical applications of coronary sinus retroperfusion during high risk PTCA JAm Col Cardiol 1993; 22:127-34
193. 1993 ST-segment recovery as an endpoint in acute myocardial infarction trials:Past, present and future. JElectrocard1993; 26(suppl):256-61
194. 1993 Treatment of long coronary artery narrowings with long angioplasty balloon catheters. Am J Cardiol1993; 71(15):1274-7
195. 1993 Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations Am J Cardiol 1993; 71:145-151
196. 1992 Unstable infarct artery:Quantification across angiographic subgroups using continuous digital 12-lead ST-segment recovery analysis J Electrocard 1992; 24(suppl):15.
197. 1992 The relative roles of clinical variables and continuous ST segment monitoring for "real time" noninvasivedetection of reperfusion in the TAMI 7 trial Circulation 1992.
198. 1992 Detection of Recurrent Ischemia with Continuous Electrocardiographic Monitoring:Early Risk Stratification Following Thrombolytic Therapy Circulation, 1992
199. 1992 "Over the shoulder" guidewire manipulation through an angulated stenosis adjacent to a coronary aneurysm during high risk percutaneous transluminal angioplasty JInterven Cardiol 1992:5:323-330.
200. 1992 Evolution of an automated ST-Segment analysis program for Dynamic real-time, noninvasive detection of coronary occlusion and reperfusion J Electrocard 1992; 25(suppl):182-187
201. 1992 Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans J Am ColCardiol1992; 20(3):594-8
202. 1992 Principal component analysis of 32 lead body surface maps:a promising noninvasive approach to the detection of coronary artery disease at rest Circulation. 1992
203. 1991 Heuristic analysis of continuous digital ST segmenttrend patterns for emulated "real time"detection of reperfusion: correlation in the TAMI 7 trial Computers in Cardiol1991.
204. 1991 From HIRMIT* to the Cape May Lighthouse North Carolina Med J1991; 52:12:618-620
205. 1991 Intracoronary ultrasound evaluation of interventional technologies Am J Cardiol 1991; 68:1305-1309
206. 1991 Quantification of ST-segment changes during coronary angioplasty in patients with left bundle Branch block. Am J Cardiol 1991:1219-1222
207. 1991 Performance of an automated real time ST-segment analysis program to detect Coronary occlusion and reperfusion ComputersIn Cardiology1991.
208. 1991 Hugging Balloons" Through a single 8-French guide: salvage angioplasty with lytic therapy in the infarct vessel of a 40-year-old man Catheterization and Cardiovascular Diagnosis 1991; 24:45-50.
209. 1990 Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated fluosol. Am J Cardiol 1990; 66:279-284
210. 1990 Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty Circulation 1990; 81(supplIV):IV-20-IV-26
211. 1990 Prospective blinded noninvasive detection of failed thrombolysis using trending from continuous 12- lead ST segment monitoring Circulation Abstract 1990 AHA.
212. 1990 Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring Am J Cardial 1990; 66:1509-12
213. 1990 Heuristic and logistic principles of ST-segment interpretation in the time domain, evolution in the context of the TAMI 7 trail design JElectrocard 1990; 23 (suppl):6-10.
214. 1990 Myocardial salvage after failed coronary angioplasty J Am Col Card 1990; 15(1):78-82.
215. 1990 The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor:A preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion. Am J Cardiol 1990; 65:143-8
216. 1989 Transient alterations of the QRS Complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries Am J Cardiol 1989; 63:1208-1213
217. 1989 Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary fluosol Am Heart J 1989;118: 679-85
218. 1989 Electrocardiographic monitoring and coronary occlusion; fingerprint pattern analysis in dimensions of space, time, and mind. J Electrocard1989; 22(suppl):232-7
219. 1989 Clinical safety and early course following prolongedinflations in elective transluminal coronary angioplasty. J Am Col Cardiol 1989; 13:43A.
220. 1989 Continuous computer-assisted electrocardiographic monitoring in patients with acute myocardial infarction:Early experience Computers In Cardiol 1989; 197-200.
221. 1989 Electrocardiographic patterns of impending coronary closure independent of unstable anginal symptoms Predisposing Conditions for Acute Ischemic Syndromes, von Arnim T., Maseri A. eds., Springer-Verlag, Darmstadt, 1989.
222. 1989 Instrumentation and practice standards for electrocardiographic monitoring in special care units:A Report for Health Professionals by a Task Force of the Council on Clinical Cardiology, American Heart Association Circulation 1989; 79:464-471.
223. 1988 Transient alterations of the QRS complex and the ST segment during balloon angioplasty of the left anterior descending artery Am J Cardiol 1988; 62:1038-1042.
224. 1988 Preoperative ischemia as a predictor of perioperative infarction in patients undergoing coronary revascularization Clin Res 1988; 36:7A.
225. 1988 Metabolic preloading reduces ischemic burden during angioplasty Clin Res1988; 36:7A
226. 1988 ST segment localization of coronary occlusion Clin Res1988; 36:5A.
227. 1988 Slow ST segment recovery after balloon deflation:Poor prognosis despite angiographic success after angioplasty Clin Res1988; 36:5A
228. 1988 Poor performance of single lead monitoring for silent and symptomatic ischemia:Quantitation with angiographic definition Clin Res1988; 36:5A
229. 1988 Pitfalls of 1 and 2 lead ST segmentrecording of silent or symptomatic ischemia. Circulation 1988;78:(suppl II; II-24).
230. 1988 Epicardial anatomy of electrocardiographic silence during 1474 coronary occlusions. Circulation1988; (suppl II):78:578:1988
231. 1988 Identification of two discrete lateral precordial zones using, continuous 12 lead ST monitoring during coronary occlusion Circulation1988; 78: (suppl II; II-241).
232. 1988 Effect of aspirin (ASA) on complications during transluminal coronary angioplasty (TCA). JACC1988; 11:132A
233. 1988 Myocardial salvage after failed angioplasty JACC 1988; 11:133A
234. 1988 Identification of high risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multi-lead monitoring Am J Cardiol 1988; 61:29F-34F
235. 1988 Treatment of non-cardiogenic pulmonary edema following cardiopulmonary bypass with veno-venous extracorporeal membrane oxygenation Anesthesiology1988; 69(4):609-614.
236. 1988 Quantitative ST-segment recovery following angiographically successful angioplasty:A useful warning of early complication J Electrocard 1988; 21(suppl):S27-S29
237. 1988 Stability of multi-lead ST segment "fingerprints" over time following angioplasty:A new approach to noninvasive detection of reocclusion Am J Cardiol 1988; 61:1232-1237
238. 1988 Poor performance of lead V5 in Single- and dual-channel ST-segment monitoring during coronary occlusion J Electrocard1988; 21(suppl):30-34.
239. 1987 Fading ischemia during transluminal coronary angioplasty (TCA):Correlation with systematic beta blockade Circulation1987;76:(SupplII;IV-184)
240. 1987 Silent and symptomatic ischemia after angioplasty: detection with continuous and real-time STsegment monitoring. JACC 1987; 9:68A
241. 1987 Computer-assisted ST-segment monitoring:Experience during and after brief coronary occlusion J Electrocard1987; 20(suppl):15-21
242. 1987 Quantitation of ischemia during total coronary occlusion with computer-assisted high resolution ST segment monitoring:Effect of collateral flow J Electocard 1987; 20(suppl):104-106.
243. 1987 ST segment changes during acute myocardial infarction Acute Coronary Care 1987, R.M. Califf and G.S. Wagner (eds.), Martinus Nijhoff Publishing, Boston, 1987:125-164
244. 1987 Dedicated ST-segment monitoring in the CCU after successful coronary angioplasty:incidence and prognosis of silent and symptomatic ischemia Silent Ischemia: Current Concepts and Management, V. Armin, Maseri Ed.Steinkopff Verlag Darmstadt publ,1987.
245. 1986 Characterization of "fading ischemia" during serial angioplasty dilatations using high resolution ST segment analysis Proceedings of the 2nd InternationalSymposium on Holter Monitoring.1986.
246. 1986 Safety of beta blockers with coronaryangioplasty. J Am Col Cardiol 1986;7: 239A
247. 1986 Salvage of myocardium after thrombolysis predicted by quantitative ST segment analysis Clin Res 1986;34: 171A.
248. 1986 The development of ischemia despite collaterals duringangioplasty. Clin Res 1986;34: 171A.
249. 1986 Documentation of fading ischemia duringcoronary angioplasty by continuous ST segment analysis Clin Res 1986;34: 171A.
250. 1986 A comparison between beta and calciumchannel blockers during coronary angioplasty. Clin Res 1986;34: 171A.
251. 1986 NA The New Yoga for Healthy Aging. Deerfield Beach, FL: Health Communications, Inc., 2007:xv-xx.
252. 1986 Beta blocker safety after coronary angioplasty:quantification by high resolution ST segment analysis. Clin Res 34:172A; 1986.
253. 1986 The absence of complete collaterals protection with angioplasty ClinRes1986; 34:859A.
254. 1986 Intracoronary perfluorochemical infusion causes ST-segment elevation but no change in regional wall motion. Clin Res1986; 34:864A
255. 1986 ST segment elevation after angioplasty:early detection of impending infarction Circulation 1986; 74:(suppl II):194.
256. 1986 Quantitative reduction of ischemia during angioplasty:distal coronary perfusion with oxygenated fluosol Circulation 1986; 74(suppl II).
257. 1986 Ischemia in the presence of angiographic collateralsduring angioplasty:characterization with high resolution analysis of continuous ST segment recordings Proceedings of the2nd International Symposium on Holter Monitoring 1986.
258. 1986 Future directions for the diagnosis and treatment of acute myocardial infarction Acute Myocardial Infarction: Emerging Concepts of Pathogenesis and Treatment, in press. Praeger publ,1986.
259. 1986 Ventricular arrhythmias during reperfusion. Am Heart J 1986; 112: 928-932.
260. 1986 Noninvasive detection of coronary artery patency using continuous ST segment monitoring Am J Cardiol 1986; 57; 916-922
261. 1985 Ventricular arrhythmias associated with thrombolysis in acute myocardial infarction J Am Col Cardiol 1985;5: 522.
262. 1985 ST segment monitoring as a predictor of thrombolysis in acute myocardial infarction. J Am Col Cardiol 1985;5: 522
263. 1984 Noninvasive determination ofsubtotal coronary occlusions with Holter monitoring Circulation 1984; 70(II):435.
264. 1984 Noninvasive assessment ofmyocardial reperfusion with Holter monitoring Circulation 1984; 70(II):155
265. 1984 The incidence of ventricular arrhythmias in reperfused versus non‑reperfused infarct vessels during acute myocardial infarction Clin Res 1984;32: 678A.
266. 1984 Continuous ST segment Holter monitoring for assessment of myocardial reperfusion. Clin Res 1984; 32:675A.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.